DIGIANDOMENICO ANTHONY

Average Profitability
68.36%
Insider Buys Quantity
12
Insider Buys Sum
$690,933.13
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of DIGIANDOMENICO ANTHONY

According to the SEC Form 4 filings, DIGIANDOMENICO ANTHONY, being in a position of

  1. Co-Founder at MDB Capital Holdings, LLC Class A common,
    оver the last 12 months, has bought 3693 shares for $22,954, and sold 0 shares,
    over all time since 2024-12-17, has bought 3693 shares for $22,954, and sold 0 shares.

The largest purchase of all time was on 2018-12-27 and amounted to 40000 shares of Cue Biopharma, Inc. for $190,800.

Biography of DIGIANDOMENICO ANTHONY

No biography is available at this moment.

2024-12-19PurchaseMDB Capital Holdings, LLC Class A common
MDBH
Co-Founder
1,000
0.01%
$6.24$6,240+1.58%
2024-12-18PurchaseMDB Capital Holdings, LLC Class A common
MDBH
Co-Founder
1,000
0.0101%
$6.20$6,200+2.24%
2024-12-17PurchaseMDB Capital Holdings, LLC Class A common
MDBH
Co-Founder
1,693
0.017%
$6.21$10,514+1.93%
2023-05-02PurchaseENDRA Life Sciences Inc.
NDRA
director
83,333
3.2618%
$1.20$100,000-32.94%
2020-06-08PurchaseENDRA Life Sciences Inc.
NDRA
director
5,000
0.15%
$0.92$4,600+4.75%
2020-05-28PurchaseENDRA Life Sciences Inc.
NDRA
director
5,000
0.1468%
$0.90$4,500+5.06%
2020-05-22PurchaseENDRA Life Sciences Inc.
NDRA
director
10,000
0.2544%
$0.78$7,800+17.72%
2018-12-28PurchaseCue Biopharma, Inc.
CUE
director
14,000
0.0692%
$4.62$64,680+72.84%
2018-12-27PurchaseCue Biopharma, Inc.
CUE
director
40,000
0.2012%
$4.77$190,800+70.28%
2018-12-24PurchaseCue Biopharma, Inc.
CUE
director
20,000
0.1048%
$4.81$96,200+75.66%
2018-12-21PurchaseCue Biopharma, Inc.
CUE
director
20,000
0.0967%
$4.49$89,800+73.75%
2018-12-17PurchaseCue Biopharma, Inc.
CUE
director
20,000
0.1017%
$5.48$109,600+49.25%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.